Treatment Response Of Cns High-Grade Neuroepithelial Tumors Withmn1alteration

Central nervous system high-grade neuroepithelial tumor withMN1alteration (CNS HGNET-MN1) is a rare recently described entity. Fourteen CNS HGNET-MN1patients were identified using genome-wide methylation arrays/RT-PCR across seven institutions. All patients had surgery (gross total resection: 10; subtotal resection: four) as initial management followed by observation alone in three patients, followed by radiotherapy in eight patients (focal: five; craniospinal: two; CyberKnife: one) and systemic chemotherapy in three patients. Seven patients relapsed; five local and two metastatic, despite adjuvant radiotherapy, of which three died. Treatment of CNS HGNET-MN1remains a major treatment challenge despite aggressive surgical resections and upfront radiotherapy, warranting new approaches to this rare malignancy.